May 24, 2018 – By reb123z Crispr Therapeutics Aghares (NASDAQ:CRSP) had an increase of 0.65% in short interest. CRSP’s SI was 2.42 million shares in May as released by FINRA. Its up 0.65% from 2.40M shares previously. With 1.03 million avg volume, 2 days are for Crispr Therapeutics Aghares (NASDAQ:CRSP)’s short sellers to cover CRSP’s […]

CRISPR Therapeutics AG (NASDAQ:CRSP) CRISPR Therapeutics AG (NASDAQ:CRSP) represented a move of 9.11 percent or $-6.25 per share and closed its previous day trading session at $69.57. 1.94 Million Shares were traded in the last trading session with an Average Volume of 1.33 Million Shares. The stock currently has a Market Capitalization of 3.32 Billion. […]

May 24, 2018 New Enterprise Associates Inc. (NEA), a US-based venture capital firm, on Wednesday announced the promotion of two members of its investing team, Carmen Chang and Ali Behbahani, to the position of general partner. While Chang joined NEA in 2012, and was promoted to Chairman and Head of the firm’s Asia practice in 2016, Behbahani joined NEA in […]

CRISPR Therapeutics (NASDAQ: CRSP) and Amgen (NASDAQ:AMGN) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability. Analyst Recommendations This is a summary of recent ratings and target prices for CRISPR Therapeutics and […]

How Does CRISPR Work? Published May 23, 2018 Andre Fenton: CRISPR stands for: clustered, regularly, interspaced, short, palindromic, repeats. That’s why it’s just called “CRISPR”. First discovered in bacteria, CRISPRs are like bacterial immune systems. They have two key parts: a destroyer protein—like one called CAS 9—and a piece of RNA that matches old viruses […]

Heading into the close, a volume-active day saw Encana Corporation (NYSE:ECA) moving down $-0.47 from the opening price. The volume for the company on May 22, 2018 consisted of nearly 10.36 million contracts traded. Over the past three months, the average daily trading volume came in at about 9.61 million shares per day. The regular […]

Two Rockefeller faculty members, Gaby Maimon and Luciano Marraffini, have been named investigators of the Howard Hughes Medical Institute, a prestigious appointment that provides stable financial support over multiple years. Maimon, who is head of the Laboratory of Integrative Brain Function, and Marraffini, who is head of the Laboratory of Bacteriology, are among just 19 […]

CRISPR Therapeutics (NASDAQ:CRSP) had its price objective raised by Chardan Capital from $25.00 to $72.50 in a report published on Tuesday, May 15th, reports. Chardan Capital currently has a buy rating on the stock. Several other analysts have also recently commented on CRSP. SunTrust Banks upgraded CRISPR Therapeutics from a hold rating to a […]